Activating mutations in FLT3 are found in 25%–35% of adults with acute myeloid leukaemia (AML), most commonly in‐frame internal tandem duplications (ITD) within the intracellular juxtamembrane domain (JMD).2 The gene discussed is FLT3; the disease is acute myeloid leukemia.